You are here

Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41HL121871-01
Agency Tracking Number: R41HL121871
Amount: $215,724.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: NHLBI
Solicitation Number: PA13-089
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
RIO RANCHO, NM 87124-2281
United States
DUNS: 78651545
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (917) 617-8927
Business Contact
Phone: (917) 617-8927
Research Institution
MSC09 5220 1 University of New Mexico
ALBUQUERQUE, NM 87131-0001
United States

 () -
 Nonprofit college or university

Project Summary/Abstract The proposed effort addresses an unmet need for early diagnosis of peripheral artery disease (PAD). PAD is a disorder of vascular circulation that affects more than 8 million Americans, most of whom are unaware of its existence, risks, and threats. PAD is caused primarily by plaque-induced atherosclerosis and in some instances by blood vessel inflammation, stenosis, and injury to the limbs. It is a debilitating, underdiagnosed, undertreated, and poorly understood complication in many diseases including diabetes, sleep apnea and metabolic syndrome. Patients with PAD are 3 to 6 times more likely to have a heart attack or stroke than are patients without PAD. People with PAD have impaired function, including those who are asymptomatic,and experience a significant decline in lower-extremity functioning over time, often leading to critical limb ischemia (CLI), heart attack, and stroke. PAD is difficult to detect in the early stages, requires expensive equipment and trained technicians to

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government